Obsidian Therapeutics (OBX) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 28 71 sessions, July 28, 2026 to November 6, 2026
- Largest daily move
- +79% close of August 4, 2026
- 1-month change
- +4.9% closing prices, October 6, 2026 to November 6, 2026
Company Description
Obsidian Therapeutics (NASDAQ: OBX) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $846.3M.
OBX has gained 4.9% over the past month. The last closing price was $13.87.
For FY2025, Obsidian Therapeutics reported revenue of $0 with net income of -$100.6M and diluted earnings per share of -$7.22.
This page collects what Stock Titan holds for OBX, including price data, latest news, SEC filings, financial highlights, upcoming events, and short interest trends.
Stock Performance
Obsidian Therapeutics (OBX) closed at $13.87 on November 6, 2026. Over the past month, the price has gained 4.9%.
OBX Metrics & Rankings
Price returns through November 6, 2026. Month and year figures include the first trading day. Ranking links may use different dates.
Latest News
Obsidian Therapeutics has 4 recent news articles, with the latest published yesterday. Of the recent coverage, 2 articles coincided with positive price movement and 1 with negative movement. Key topics include clinical trial, private placement. View all OBX news →
SEC Filings
Obsidian Therapeutics has filed 10 recent SEC filings, including 5 Form SCHEDULE 13G, 1 Form 4, 1 Form EFFECT, 1 Form S-1. The most recent filing was submitted on . SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all OBX SEC filings →
Financial Highlights
Obsidian Therapeutics reported operating income of -$105.7M in FY2025, and net income was -$100.6M. Diluted earnings per share stood at -$7.22. The company generated -$90.4M in operating cash flow. The current ratio was 5.31, measuring current assets divided by current liabilities.
Upcoming Events
NSCLC Phase 1 data
Enrollment completion
Topline data release
Agni-01 enrollment completion
Melanoma topline data
Obsidian Therapeutics has 5 upcoming scheduled events. The next event, "NSCLC Phase 1 data", is expected in H1 2027. Investors can track these dates to stay informed about potential catalysts that may affect the OBX stock price.
Short Interest History
Short interest in Obsidian Therapeutics (OBX) currently stands at 1.1 million shares, up 22.3% from the previous reporting period, representing 1.8% of the float. Since August 2026, short interest has increased by 2895.8%.
Days to Cover History
Days to cover for Obsidian Therapeutics (OBX) currently stands at 3.2 days, up 222% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Since August 2026, the figure has increased by 222%. Across the settlements charted above, it has ranged from 1.0 to 3.2 days.
OBX Company Profile & Sector Positioning
Obsidian Therapeutics (OBX) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NASDAQ.
Investors comparing OBX often look at related companies in the same sector, including Corvus Pharmaceuticals, Inc. (CRVS), Aktis Oncology, Inc. (AKTS), Pharming Group N.V. (PHAR), MeiraGTx Holdings plc (MGTX), and Syndax Pharmaceuticals, Inc. (SNDX). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate OBX's relative position within its industry.